Table 2 Unadjusted outcomes during... | American Society of Hematology

Table 2

Unadjusted outcomes during 180-day follow-up period

Characteristic	Stable group, n = 2504	Comparator group, n = 3569	P
Received heparin,* %	0.3	3.2	< .001
Deceased, n, %	10, 0.4	58, 1.6	< .001
AC-related death, n, %	1, 0.04	5, 0.1	.411†
AC-related thrombosis, n, %	10, 0.4	26, 0.7	.100
AC-related bleeding, n, %	19, 0.8	101, 2.8	< .001
AC-related bleeding or thrombosis, n, %	28, 1.1	127, 3.6	< .001

Characteristic	Stable group, n = 2504	Comparator group, n = 3569	P
Received heparin,* %	0.3	3.2	< .001
Deceased, n, %	10, 0.4	58, 1.6	< .001
AC-related death, n, %	1, 0.04	5, 0.1	.411†
AC-related thrombosis, n, %	10, 0.4	26, 0.7	.100
AC-related bleeding, n, %	19, 0.8	101, 2.8	< .001
AC-related bleeding or thrombosis, n, %	28, 1.1	127, 3.6	< .001

AC indicates anticoagulation.

Heparin or low-molecular-weight heparin.

Fisher exact test.